| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 04/30/2002 | US6380397 Halogenation an oxoester compound; hydrolysis and decarboxylation; alkylation; amination; reacting oxaly chloride |
| 04/30/2002 | US6380249 HIV integrase inhibitors |
| 04/30/2002 | US6380246 For combating pests and weeds |
| 04/30/2002 | US6380242 For diagnosis and therapy of central nervous system conditions |
| 04/30/2002 | US6380239 For therapy of arthritis, rheumatoid arthritis, osteoarthritis, reperfusion injury, inflammatory bowel disease, crohn's disease, ulcerative colitis, systemic lupus erythrematosis, scleroderma, aphthous ulcers, asthma |
| 04/30/2002 | US6380238 Indoline derivatives as 5-HT2B and or 5-HTC receptor ligands |
| 04/30/2002 | US6380230 For therapy of dyskinesia, obesity, irritable bowel syndrome, diseases whose treatment requires stimulation of the cholecystokinin cck-a receptors |
| 04/30/2002 | US6380201 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists |
| 04/30/2002 | US6380185 N-substituted benzoyl indoles as estrogenic agents |
| 04/30/2002 | US6379655 For protection of human skin and/or hair against the damaging effects of ultraviolet irradiation |
| 04/25/2002 | WO2002033110A2 PRODUCTION OF α-HYDROXY-CARBOXYLIC ACIDS USING A COUPLED ENZYME SYSTEM |
| 04/25/2002 | WO2002032960A2 Methods of selecting compounds for modulation of bladder function |
| 04/25/2002 | WO2002032901A2 Bridged piperazine derivatives |
| 04/25/2002 | WO2002032864A1 Pharmaceutically active sulfanilide derivatives |
| 04/25/2002 | WO2002032863A1 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy |
| 04/25/2002 | WO2002032860A2 Dynamic organ function monitoring agents |
| 04/25/2002 | WO2002032465A1 Tissue-specific exogenous optical agents |
| 04/25/2002 | WO2002032464A1 Novel dyes for organ function monitoring |
| 04/25/2002 | WO2002032443A1 Saururus chinensis extract for prevention and treatment of neurodegenerative disease |
| 04/25/2002 | WO2002032421A1 Indole compounds as minimally physiologial function monitioring agents |
| 04/25/2002 | WO2002032419A2 Methods for modulating bladder function |
| 04/25/2002 | WO2002032389A1 Method of treating stroke |
| 04/25/2002 | WO2002032285A2 Hydrophilic light absorbing compositions for determination of physiological function in critically ill patients |
| 04/25/2002 | WO2001097810A3 Use of therapeutic benzamide derivatives |
| 04/25/2002 | WO2001058891A3 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage |
| 04/25/2002 | WO2001047913A3 Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect |
| 04/25/2002 | WO2001002369A3 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 04/25/2002 | US20020049335 DNA alkylating compounds such as 1-(tert-butyloxycarbonyl) -4-hydroxy-3(((methane-sulfonyl)oxy)methyl)-2,3-dihydroindole |
| 04/25/2002 | US20020049328 Such as (R)-1-Cyclopropyl-8-difluoromethoxy-7-(1-methyl-2,3-dihydro-1H-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxyl ic acid methanesulfonate; chemical intermediates; bactericides; catalysis |
| 04/25/2002 | US20020049234 Inhibitors of factor Xa; for example 3-(4-tert-butylbenzoyl)amino-N-(4-methoxyphenyl)-2-thiophenecarboxamide |
| 04/25/2002 | US20020049231 S(-)-3-aminothalidomide; treating wide variety of diseases including diabetic retinopathy |
| 04/25/2002 | US20020049226 Treating obesity, hyperlipidemia, glaucoma, arrhythmia, skin disorders, thyroid disease, hypothyroidism, diabetes mellitus, atherosclerosis, hypertension, coronary heart disease, hypercholesteremia, depression and osteoporosis |
| 04/25/2002 | US20020049211 Combination treatment for depression and anxiety |
| 04/25/2002 | US20020049209 Dopamine D4 ligands for the treatment of novelty-seeking disorders |
| 04/25/2002 | US20020049198 Administering to a patient having or at risk of having osteoarthritis, a therapeutically effective amount of an bicyclicaromatic or heteroaromatic compound containing amine and hydroxy groups |
| 04/25/2002 | US20020049135 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
| 04/25/2002 | US20020048687 Efficient light emission and excellent heat resistance |
| 04/25/2002 | US20020048645 Regenerating with a higher density |
| 04/25/2002 | CA2426594A1 Production of .alpha.-hydroxy-carboxylic acids using a coupled enzyme system |
| 04/25/2002 | CA2425742A1 Methods of selecting compounds for modulation of bladder function |
| 04/25/2002 | CA2425718A1 Dynamic organ function monitoring agents |
| 04/25/2002 | CA2425701A1 Indole compounds as minimally physiologial function monitioring agents |
| 04/25/2002 | CA2425698A1 Hydrophilic light absorbing compositions for determination of physiological function in critically ill patients |
| 04/25/2002 | CA2423933A1 Pharmaceutically active sulfanilide derivatives |
| 04/25/2002 | CA2423789A1 Bridged piperazine derivatives |
| 04/25/2002 | CA2422717A1 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy |
| 04/25/2002 | CA2420994A1 Method of treating stroke |
| 04/24/2002 | EP1199071A2 Use of an estrogen agonist/antagonist for improving vascular health |
| 04/24/2002 | EP1198456A2 Potassium channel openers |
| 04/24/2002 | EP1198454A1 Mutilin derivatives and their use as antibacterials |
| 04/24/2002 | EP1198453A2 N-(indolcarbonyl-)piperazin derivatives |
| 04/24/2002 | EP0782568B1 Aromatic ethers derived from indols such as 5ht1-like ligands |
| 04/24/2002 | CN1346343A 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors |
| 04/24/2002 | CN1346272A Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 04/24/2002 | CN1346271A Quinazoline derivatives as angiogenesis inhibitors |
| 04/24/2002 | CN1083443C 吲哚衍生物 Indole derivatives |
| 04/24/2002 | CN1083430C Carbazolone derivatives |
| 04/24/2002 | CN1083429C Substituted alkyldiamine derivatives and their use as tachykinin antagonists |
| 04/24/2002 | CN1083263C Use of melatonin for treating patients suffering from drug addiction |
| 04/23/2002 | US6376670 Bactericide for grampositive bacteria |
| 04/23/2002 | US6376538 Antiinflammatory agents; autoimmune diseases |
| 04/23/2002 | US6376530 A n-methylaspartic acid antagonist; nervous system disorders, analgesics |
| 04/23/2002 | US6376529 Mono- and bis-indolylquinones and prophylactic and therapeutic uses thereof |
| 04/23/2002 | US6376510 Administering a alkoxy- and acyloxy-substituted aralkyl and aralkenyl bis quaternary ammonium derivatives of cyclic alkanol diesters to a human as muscle relaxants |
| 04/23/2002 | US6376494 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
| 04/23/2002 | US6376428 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production |
| 04/18/2002 | WO2002030895A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-η BINDING AGENTS |
| 04/18/2002 | WO2002030894A2 Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins |
| 04/18/2002 | WO2002030881A1 Sulfonylguanidine |
| 04/18/2002 | WO2002030879A2 Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
| 04/18/2002 | WO2002030868A1 Selective maxi-k- potassium channel openers functional under conditions of high intracellular calcium concentration, methods and uses thereof |
| 04/18/2002 | WO2002030867A2 Drugs for diabetes |
| 04/18/2002 | WO2002030406A2 Use of antagonists or partial agonists of 5ht1a receptors for the preparation of a medicament for treatment and prevention of gastrointestinal diseases |
| 04/18/2002 | WO2002017914A3 Fused pyrrolocarbazoles against inflammation |
| 04/18/2002 | WO2002012166A3 Triamine derivative melanocortin receptor ligands and methods of using same |
| 04/18/2002 | WO2002003995A3 Treatment of male sexual dysfunction |
| 04/18/2002 | WO2002002488A3 Methods and compounds for modulating nuclear receptor coactivator binding |
| 04/18/2002 | WO2001058893A3 Indol-3-yl derivatives and their use as integrin inhibitors |
| 04/18/2002 | WO2001056353A3 Novel method for synthesis of n-[(s)-1-carboxybutyl]-(s)-alanine esters and use in synthesis of perindopril |
| 04/18/2002 | US20020045777 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes. |
| 04/18/2002 | US20020045749 Antibacterial agents |
| 04/18/2002 | US20020045662 Stable gabapentin having pH within a controlled range |
| 04/18/2002 | US20020045650 Substituted indole proteolytic enzyme inhibitors as cancer treating agents |
| 04/18/2002 | US20020045628 Antidepressants; anxiolytic agents; serotonin-affected nervous system disorders; acting at the 5-HT1a autoreceptors concommitantly with 5-HT transporters; antiserotonin agents; serotonin reuptake inhibitors; HT3 receptor antagonists |
| 04/18/2002 | US20020045626 Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands |
| 04/18/2002 | US20020045617 Act preferentially on M4 receptors; side effect reduction; used to treat nervous system disorders, psychological disorders and as an analgesic; Alzheimer's disease; Cognition activators. |
| 04/18/2002 | US20020045581 Method for reducing or preventing the establishment, growth or metastasis of cancer by administering PAR-1 and optionally PAR-2 antagonists |
| 04/18/2002 | US20020045566 Selective maxi-K potassium channel openers functional under conditions of high intracellular calcium concentration, methods and uses thereof |
| 04/18/2002 | US20020044909 Cyanine dye bioconjugates with bioactive molecules for diagnosis and therapy, particularly for visualization and detection of tumors |
| 04/18/2002 | CA2765409A1 Hydroxamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
| 04/18/2002 | CA2427499A1 Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppar-.gamma. binding agents |
| 04/18/2002 | CA2425910A1 Treatment and prevention of gastrointestinal disease using antagonists or partial agonists of 5ht1a receptors |
| 04/18/2002 | CA2425771A1 Selective maxi-k- potassium channel openers functional under conditions of high intracellular calcium concentration, methods and uses thereof |
| 04/18/2002 | CA2425655A1 Drugs for diabetes |
| 04/18/2002 | CA2424107A1 Sulfonylguanidines |
| 04/17/2002 | EP1197484A2 1H-Indole-3-glyoxylamide sPLA2 inhibitors |
| 04/17/2002 | EP1196418A1 METHOD FOR PREPARING SUBSTITUTED 1,4]DIAZEPINO 6,7,1- i hi /i ]INDOL-4-ONES |
| 04/17/2002 | EP1196397A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 04/17/2002 | EP1196389A1 N-heterocyclic derivatives with neuronal activity |
| 04/17/2002 | EP1196381A2 Process for the preparation of n-(1,1-dimethylethyl)-4-((5'-ethoxy-4-cis-(2-(4-morfolino)ethoxy)-2'-oxospiro(cyclohexan-1,3'-(3h)indol)-1'(2'h)-yl)-sulfonyl)-3-methoxybenzamide and its salts |